Back to News
Market Impact: 0.15
Sionna Therapeutics Reaches Analyst Target Price
Source: Nasdaq
Analyst InsightsAnalyst EstimatesInvestor Sentiment & PositioningCompany Fundamentals
Sionna Therapeutics (SION) shares moved above the average 12-month analyst target of $5.50, trading around $5.59 (about +1.6% vs. target). The article frames this as a point where analysts typically consider whether to re-rate or adjust expectations, but no new earnings, guidance, or fundamental catalysts are provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.08
Ticker Sentiment
SION0.25
More News
- ‘The gap was not the awareness’: The company phishing trainings you loathe aren’t enough when nearly 1 in 4 security pros say their MFA is optional
- Why is T-Mobile stock tumbling today?
- Why is Verizon stock sliding today?
- SpaceX wants to become a 'major mobile carrier' with low-band spectrum acquisition
- OpenAI projected to bring in $20bn less in revenue than expected
- Soitec climbs 7% as BofA turns bullish on silicon photonics demand